Stay updated on MK-3475 Combo vs Chemotherapy in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the MK-3475 Combo vs Chemotherapy in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MK-3475 Combo vs Chemotherapy in Ovarian Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The record describes a Phase 2 study comparing pembrolizumab plus chemotherapy with chemotherapy alone for recurrent, platinum-resistant ovarian cancer. It includes the study design, participant criteria, contact and location details, and measured outcomes.
    Difference
    56%
    Check dated 2026-11-08T17:08:07.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0 while the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T17:14:55.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a terminology change from “Artificial Intelligence” to “Super Intelligence” during a transition period.
    Difference
    1%
    Check dated 2026-10-25T18:18:32.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-18T22:30:37.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The site revision identifier changed from v3.7.0 to v3.7.1; the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T22:31:30.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    A new site revision banner (Revision: v3.7.0) was added and a broad set of terms and sections related to drugs, diseases, and study metadata were removed, reflecting a metadata/terminology cleanup rather than changes to the study data.
    Difference
    20%
    Check dated 2026-09-20T20:35:43.000Z thumbnail image

Stay in the know with updates to MK-3475 Combo vs Chemotherapy in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MK-3475 Combo vs Chemotherapy in Ovarian Cancer Clinical Trial page.